T. Rowe Price Associates’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-36,531
| Closed | -$244K | – | 2936 |
|
|
2023
Q3 | $244K | Buy |
36,531
+9,558
| +35% | +$63.8K | ﹤0.01% | 2420 |
|
|
2023
Q2 | $245K | Sell |
26,973
-9,820
| -27% | -$89.2K | ﹤0.01% | 2452 |
|
|
2023
Q1 | $268K | Sell |
36,793
-2,262
| -6% | -$16.5K | ﹤0.01% | 2400 |
|
|
2022
Q4 | $285K | Sell |
39,055
-10,920
| -22% | -$79.7K | ﹤0.01% | 2389 |
|
|
2022
Q3 | $387K | Buy |
+49,975
| New | +$387K | ﹤0.01% | 2255 |
|
|
2021
Q1 | – | Sell |
-921,822
| Closed | -$12.9M | – | 2877 |
|
|
2020
Q4 | $12.9M | Hold |
921,822
| – | – | ﹤0.01% | 1315 |
|
|
2020
Q3 | $13.3M | Buy |
+921,822
| New | +$13.3M | ﹤0.01% | 1232 |
|